09.09.2019
DCL has recently reached an agreement with JW pharmaceutical Corporation, a leading Korean pharmaceutical corporation to transfer all of DCL’s equity in Euvipharm n August 30, 2019 This can be said to be a deal that benefits many parties, including sellers, buyers and opens a bright future for Euvipharm. JW pharmaceutical Corporation is the leading […]